ACI-19764 at dose B3: clinical trials recruiting now

Fewer than 3 recruiting trials found.

1

Recruiting trials

4

Conditions studied

0

US states with sites

1

Countries

Phase breakdown

Phase 1 1

Conditions being studied

Condition	Trials
Healthy Participants	1
Obesity	1
Type 2 Diabetes Mellitus (T2DM)	1
Type 2 diabetes	1

Recruiting trials involving ACI-19764 at dose B3

A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants and in Participants With Cardiovascular Risk Factors
NCT07463196 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 2 locations

Common questions

How many recruiting trials involve ACI-19764 at dose B3?

1 recruiting trial across 4 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.